Sign in
4

Changes in Ownership

Mosaic ImmunoEngineering Inc. Filed Acc 0001233397-04-000004

Options or other derivatives

  • President and CEO acquired 173,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
WALLIN JEFFREY E President and CEO 2003-12-18 Grant or award · 2003 Stock Option Plan +173,000 $0.03 $5,969 173,000 I: show line 1 in the form
Loading xslF345X02/primary_doc.xml…